Released: 02/02/2010
2 February 2009, London, UK, and Cambridge, MA: Antisoma plc (LSE: ASM; USOTC: ATSMY) announces that Daniel Elger, VP Marketing & Communications, will present an overview of the Company's strategy, programmes and prospects at the 12th Annual BIO CEO & Investor Conference in New York on Monday, 8th February at 8:30am EST/1:30pm GMT. A webcast of the presentation will be available on Antisoma's website at http://www.antisoma.com/asm/media/webcast/ For live viewing of the webcast, it is recommended that viewers log on 15 minutes early in order to register and download any necessary software. Enquiries: Alison Saville Senior Marketing and Communications Executive Antisoma plc +44 (0)20 3249 2144 Background on Antisoma Antisoma is a London Stock Exchange-listed biopharmaceutical company that develops novel products for the treatment of cancer. The Company has operations in the UK and the US. Please visit www.antisoma.com for further information about Antisoma. HUG#1379580